---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-038095"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2023-08-04T23:59:59+00:00"
generated_at: "2026-06-12T05:50:35.093917+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics effects 1-for-10 reverse stock split, effective August 4, 2023

## Summary
- Reverse stock split at ratio 1:10 effective 5:00 p.m. ET on August 4, 2023; trading on split-adjusted basis begins August 7, 2023.
- No fractional shares issued; stockholders otherwise entitled to fractional share receive cash in lieu.
- Proportionate adjustments to per-share exercise price and shares of stock options, RSUs, and warrants.
- Certificate of Elimination filed for Series A Preferred Stock (no shares outstanding), removing designation from charter.

## SEC filing metadata
- accession: 0001140361-23-038095
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2023-08-04T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/0001140361-23-038095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/brhc20056936_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-038095
- JSON: https://secwatch.observer/filing/0001140361-23-038095.json
- Plain text: https://secwatch.observer/filing/0001140361-23-038095.txt

## Key facts
- Governance Changes
  Bionano Genomics, Inc.: Amended certificate of incorporation to effect a 1-for-10 reverse stock split (effective 2023-08-04).
  - Change: charter amendment
  - Effective: 2023-08-04
  source text: On August 4, 2023, Bionano Genomics, Inc. (the “ Company ”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “ Restated Certificate ”), with the office of the Secretary of State of the State of Delaware to effect a reverse stock split at a ratio of 1:10 (the “ Charter Amendment ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/0001140361-23-038095-index.htm
- Governance Changes
  Bionano Genomics, Inc.: Filed certificate of elimination to remove designation of Series A Preferred Stock and restore it to undesignated authorized preferred shares (effective 2023-08-04).
  - Change: charter amendment
  - Effective: 2023-08-04
  source text: On August 4, 2023, prior to the Company’s filing of the Charter Amendment with the office of the Secretary of State of the State of Delaware, the Company filed a Certificate of Elimination (the “ Certificate of Elimination ”) with the office of the Secretary of State of the State of Delaware with respect to the Company’s Series A Preferred Stock, par value $0.0001 per share (the “ Series A Preferred Stock ”), following the automatic redemption of all outstanding shares of Series A Preferred Stock after the conclusion of the 2023 Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411690/000114036123038095/0001140361-23-038095-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.